First-in-human study of EI-1071 shows safety and tolerability in healthy volunteers
The study evaluated the safety, tolerability, and pharmacokinetics of EI-1071 in healthy volunteers.
Company
Pharmaceutical intelligence for pharmaceutical developers with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.